PAI Holdings recalls

PAI Holdings has 11 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 24 Jun 2026. 4 are still ongoing. 4 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls11since 2020

Last 12 months4reported

Class I00% of total

Ongoing4latest 24 Jun 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 1Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 4 0 0Aug 0 0

Severity split

Class I 0 0%Class II 9 82%Class III 2 18%

Why pai holdings is recalled

Product types

Antidepressants19%
Cold & Cough Medicine19%

Brands

By year

2026436%
202519%
2021327%
2020327%

Ongoing pai holdings recalls

4 active

Reported	Class	Recall	Company	Reason	Where
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Sorbitol Base With Cherry recalled	PAI Holdings	Other	Nationwide
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Aqueous Base With Cherry recalled	PAI Holdings	Other	Nationwide
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Sorbitol Base With Cherry recalled	PAI Holdings	Other	Nationwide
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Aqueous Base With Cherry recalled	PAI Holdings	Other	Nationwide

All pai holdings recalls, newest first

11 total

Reported	Class	Recall	Company	Reason	Where
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Sorbitol Base With Cherry recalled	PAI Holdings	Other	Nationwide
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Aqueous Base With Cherry recalled	PAI Holdings	Other	Nationwide
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Sorbitol Base With Cherry recalled	PAI Holdings	Other	Nationwide
24 Jun 2026Drug	CLASS II	VistaPharm, Kerr Insta-char IN AN Aqueous Base With Cherry recalled	PAI Holdings	Other	Nationwide
12 Feb 2025Drug	CLASS III	Guaifenesin and Codeine Phosphate Oral Solution recalled by PAI HoldingsGuaifenesin And Codeine Phosphate	PAI Holdings	Potency & Assay	OH
18 Aug 2021Drug	CLASS II	Nystatin Oral Suspension, USP per mL, Cherry/Peppermint Flavor recalledNystatin	PAI Holdings	Manufacturing (CGMP) Deviations	Nationwide
18 Aug 2021Drug	CLASS II	Cimetidine Hydrochloride Oral Solution 300 mg recalled by PAI Holdings	PAI Holdings	Manufacturing (CGMP) Deviations	Nationwide
18 Aug 2021Drug	CLASS II	Ethosuximide Oral Solution USP 250 mg recalled by PAI HoldingsEthosuximide	PAI Holdings	Manufacturing (CGMP) Deviations	Nationwide
14 Oct 2020Drug	CLASS III	Citalopram Oral Solution, USP 20 mg/ unit dose cups recalled	PAI Holdings	Potency & Assay	Nationwide
19 Aug 2020Drug	CLASS II	Nystatin Oral Suspension, USP per mL, Cherry/Peppermint Flavor recalledNystatin	PAI Holdings	Potency & Assay	Nationwide
1 Apr 2020Drug	CLASS II	Nystatin Oral Suspension, USP per mL, Cherry/Peppermint Flavor recalledNystatin	PAI Holdings	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.